JPMorgan Chase Financial Company LLC, a wholly owned subsidiary of JPMorgan Chase & Co., has announced the pricing of $2,005,000 in Auto Callable Contingent Interest Notes. These notes are linked to the lesser performing of two underlyings: the Energy Select Sector SPDR Fund and the Nasdaq-100 Technology Sector Index, and are due on June 17, 2027. The notes, which are designed for investors seeking a Contingent Interest Payment for each Review Date where the underlyings' closing values are above 70% of their Initial Value, were priced on September 12, 2024, with an expected settlement date around September 17, 2024. The notes will be automatically called if the value of each underlying on any Review Date, excluding specified dates, is at or above its Initial Value. The first possible automatic...Show More

JPMorgan Chase Financial Company LLC, a wholly owned subsidiary of JPMorgan Chase & Co., has announced the pricing of $2,005,000 in Auto Callable Contingent Interest Notes. These notes are linked to the lesser performing of two underlyings: the Energy Select Sector SPDR Fund and the Nasdaq-100 Technology Sector Index, and are due on June 17, 2027. The notes, which are designed for investors seeking a Contingent Interest Payment for each Review Date where the underlyings' closing values are above 70% of their Initial Value, were priced on September 12, 2024, with an expected settlement date around September 17, 2024. The notes will be automatically called if the value of each underlying on any Review Date, excluding specified dates, is at or above its Initial Value. The first possible automatic call date is March 12, 2025. Investors are warned of the risks of losing principal and the possibility of receiving no Contingent Interest Payments. The notes are unsecured and unsubordinated obligations of JPMorgan Financial, with payments fully and unconditionally guaranteed by JPMorgan Chase & Co. The notes are not bank deposits, are not insured by any governmental agency, and involve a number of risks detailed in the accompanying prospectus supplement and product supplement.